Audit of Commodities Funded Under the President's Malaria Initiative in Kenya
USAID/Kenya coordinate with the Government of Kenya and issue an implementation letter under its development assistance grant agreement to (1) define the minimum standards acceptable for the treatment of and accounting for commodities funded by the President's Malaria Initiative and distributed through Kenyan systems, (2) confirm and record the Government of Kenya's commitment as a partner in strengthening those systems, and (3) specify the rights and responsibilities of the parties if minimum standards are not adhered to.
USAID/Kenya, in conjunction with USAID/East Africa, remind mission staff members, in writing, of their responsibility to document the removal of any official award files from their designated storage location and to return those files when no longer needed.
USAID/Kenya update its mission order on performance monitoring to give specific guidance on monitoring programs outside of one's technical program team.
USAID/Kenya remind agreement officer's representatives, in writing, of their responsibility to review and approve programs' annual work plans in accordance with the terms of each agreement.
USAID/Kenya remind agreement officer's representatives, in writing, of their responsibility to monitor recipients' performance reports in accordance with the terms of the agreement.
USAID/Kenya remind agreement officers and agreement officer's representatives, in writing, of their responsibility to monitor recipients' financial reports to ensure that each recipient makes progress toward meeting the cost-sharing requirement.
USAID/Kenya determine the allowability of $293,000 in ineligible questioned costs stemming from Population Services International's reallocation of cost savings from net distribution activities, and recover from Population Services International any amounts determined to be unallowable.
USAID/Kenya, in conjunction with USAID/Washington, obtain a cost estimate for the additional marking of artemisinin-based combination therapies and determine, in conjunction with the Division of Malaria Control and the Kenya Medical Supplies Agency, whether marking these commodities would seriously deplete funding for or otherwise interfere with the effective treatment of malaria.
USAID/Kenya, if the Division of Malaria Control and the Kenya Medical Supplies Agency agree, mark artemisinin-based combination therapies to deter theft.
USAID/Kenya notify the Office of U.S. Foreign Assistance Resources, in writing, of the misreported results for malaria-related commodity indicators in fiscal years 2010 and 2011.
USAID/Kenya update the Office of Population and Health's performance management plan to include the same indicators reported to the Office of U.S. Foreign Assistance Resources for the President's Malaria Initiative, and add the appropriate data sources.
USAID/Kenya determine and document its objectives for identifying goods and services provided under Kenya's President's Malaria Initiative as American aid and update its communication strategies, including current branding and marking plans, if they do not currently achieve those objectives.